Intraoperative application of mitomycin C in the surgical treatment of pterygium

European Journal of Ophthalmology

Volumn 8, Issue 3, 1998, Pages 153-156

  Demirok, A ^a   Simsek, S ^a   Cinal A ^a   Yasar, T ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Mitomycin C; Pterygium; Recurrence

Indexed keywords

CORTICOSTEROID; MITOMYCIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PTERYGIUM; RECURRENCE RISK; RISK MANAGEMENT; SURGICAL TECHNIQUE;

EID: 0031721621     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219800800306     Document Type: Article

References (32)

1. Mastropasqua L, Carpineto P, Ciancaglini M, Enrico Gallenga P. Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol 1996; 80: 288-91.
2. Mahar PS, Nwokora GE. Role of mitomycin C in pterygium surgery. Br J Ophthalmol 1993; 77: 433-5.
3. Pearlman G, Susal AL, Hushaw J, Bartlatt RE. Recurrent pterygium and treatment with lamellar keratoplasty with presentation of a technique to limit recurrences. Ann Ophthalmol 1970; 2: 763.
4. Zauberman H Pterygium and its recurrence. Am J Ophthalmol 1967; 63: 1780-6.
5. Youngson RM. Recurrence of pterygium after excision. Br J Ophthalmol 1972; 56: 120-5.
6. Hirst LW, Sebban A, Chant D. Pterygium recurrence time. Ophthalmology 1994; 101: 755-8.
7. Insler MS, Caldwell DR. Peripheral diseases (Terrien's and recurrent pterygium). In: Bright Bill FS, ed. Corneal surgery: theory, technique and tissue. St Louis: CV Mosby Co, 1986; 387-95.
8. Alaniz-Camino F. The use of postoperative beta radiation in the treatment of pterygia. Ophthalmic Surg 1982; 13: 1022-5.
9. Monselise M, Schwartz M, Politi F, Barishak YR. Pterygium and beta irradiation. Acta Ophthalmol 1984; 62: 315-9.
10. De-Keizner RJW. Pterygium excision with or without postoperative irradiation, a double blind study. Doc Ophthalmol 1982; 52: 309-15.
11. Tarr KH, Constable IJ. Late complications of pterygium treatment. Br J Ophthalmol 1980: 64: 496-505.
12. Boyd BF. Highlights of ophthalmology: atlas and textbook of microsurgery and laser surgery. 30th Anniversary Panama, Republic of Panama: Highlights of Ophthalmology 1984; 534-45.
13. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985; 92: 1461-70.
14. Thoft RA. Conjunctival transplantation. Arch Ophthalmol 1977; 95: 1425-7.
15. Joselson GA, Muller P. Incidence of pterygium recurrence: in patients treated with thio-tepa. Am J Ophthalmol 1966; 61: 891-2.
16. Frucht-Pery J, Siganos CS, llsar M. Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 1996; 103: 674-7.
17. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 1991; 98: 317-21.
18. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988; 95: 813-21.
19. Singh G, Wilson MR, Foster CS. Long-term follow-up study of mitomycin eye drops as adjunctive treatment of pterygia and its comparison with Conjunctival autograft transplantation. Cornea 1990; 9: 331-4.
20. Hayasaka S, Noda S, Yamamoto Y, Setogawa T. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol 1988; 106: 715-8.
21. Hayasaka S, Noda S, Yamamoto Y, Setogawa T. Postoperative instillation of mitomycin C in the treatment of recurrent pterygium. Ophthalmic Surg 1989; 20: 580-3.
22. Rubinfeld RS, Pfster RR, Stein RM, et al. Serious complications of topical mitomycin C after pterygium surgery (see comments). Ophthalmology 1992; 99: 1647-54.
23. Frucht-Pery J, llsar M, Hemo I. Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea 1994; 13: 411-3.
24. Mastropasqua L, Carpineto P, Ciancaglini M, et al. Effectiveness of intraoperative mitomycin C in the treatment of recurrent pterygium. Ophthalmologica 1994; 208: 247-9.
25. Helal M, Messiha N, Amayem A, el-Maghraby A, Elsherif Z, Dabees M. Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium. Ophthalmic Surg Lasers 1996; 27: 674-8.
26. Frucht-Pery J, llsar M. The use of low-dose mitomycin C for prevention of recurrent pterygium. Ophthalmology 1994; 101: 759-62.
27. Mahar PS, Nwokora GE. Role of mitomycin C in pterygium surgery. Br J Ophthalmol 1993; 77: 433-5.
28. Cano-Parra J, Diaz-Llopis M, Maldonado MJ, Vila E, Menezo JL. Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. Br J Ophthalmol 1995; 79. 439-41.
29. Rosenthal G, Shoham A, Lifshitz T, et al. The use of mitomycin in pterygium surgery. Ann Ophthalmol 1993; 25. 427-8.
30. Ewing Chow DA, Romanchuk KG, Gilmour GR, et al. Corneal melting after pterygium removal followed by topical mitomycin C therapy. Can J Ophthalmol 1992; 27: 197-9.
31. Gupta S, Basti S. Corneoscleral, ciliary body, and vitreoretinal toxicity after excessive instillation of mitomycin C (letter). Am J Ophthalmol 1992; 114: 503-4.
32. Ando H, Ido T, Kawai Y, et al. Inhibition of corneal epithelial wound healing. A comparative study of mitomycin C and 5-fluorouracil. Ophthalmology 1992; 99: 1809-14.